Literature DB >> 28626368

Crosstalk between Stem and Progenitor Cellular Mediators with Special Emphasis on Vasculogenesis.

Rokhsareh Rohban1,2, Barbara Prietl1,3, Thomas R Pieber1,3,4.   

Abstract

The cellular components and molecular processes of signaling during vasculogenesis have been investigated for decades. Considerable efforts have been made to unravel regulatory mechanisms of vasculogenesis through crosstalk between vasculogenic playmakers located in the vascular niche, namely hematopoietic stem cells, endothelial progenitor cells, and mesenchymal stem and progenitor cells. Recent studies have increased the knowledge about signaling events within vascular microenvironment that leads to vasculogenesis. Findings from these recent studies indicate the impact of cellular crosstalk through signaling pathways such as vascular endothelial growth factor signaling, wingless and Notch signaling in vasculogenesis and vascular development. In this review, we highlight the signaling signature between stem and progenitor cellular mediators during vasculogenesis. We further focus on hematopoietic stem cell-endothelial progenitor cell crosstalk during vasculogenesis and discuss their potential implications and benefits for therapeutic interventions and regenerative therapy.

Keywords:  Crosstalk; Endothelial progenitors; Hematopoietic stem cells; Regeneration; Signaling; Stem cells; Therapy; Transplantation; Vasculogenesis

Year:  2017        PMID: 28626368      PMCID: PMC5473070          DOI: 10.1159/000477677

Source DB:  PubMed          Journal:  Transfus Med Hemother        ISSN: 1660-3796            Impact factor:   3.747


  118 in total

1.  Integrin-mediated interactions between human bone marrow stromal precursor cells and the extracellular matrix.

Authors:  S Gronthos; P J Simmons; S E Graves; P G Robey
Journal:  Bone       Date:  2001-02       Impact factor: 4.398

2.  Physiological migration of hematopoietic stem and progenitor cells.

Authors:  D E Wright; A J Wagers; A P Gulati; F L Johnson; I L Weissman
Journal:  Science       Date:  2001-11-30       Impact factor: 47.728

3.  VEGF-mediated cell survival in non-small-cell lung cancer: implications for epigenetic targeting of VEGF receptors as a therapeutic approach.

Authors:  Martin P Barr; Kenneth J O'Byrne; Nael Al-Sarraf; Steven G Gray
Journal:  Epigenomics       Date:  2015-10-07       Impact factor: 4.778

4.  Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue.

Authors:  Susanne Kern; Hermann Eichler; Johannes Stoeve; Harald Klüter; Karen Bieback
Journal:  Stem Cells       Date:  2006-01-12       Impact factor: 6.277

5.  Smooth muscle progenitor cells from peripheral blood promote the neovascularization of endothelial colony-forming cells.

Authors:  Hyung Joon Joo; Ha-Rim Seo; Hyo Eun Jeong; Seung-Cheol Choi; Jae Hyung Park; Cheol Woong Yu; Soon Jun Hong; Seok Chung; Do-Sun Lim
Journal:  Biochem Biophys Res Commun       Date:  2014-05-22       Impact factor: 3.575

6.  Purification and characterization of mouse hematopoietic stem cells.

Authors:  G J Spangrude; S Heimfeld; I L Weissman
Journal:  Science       Date:  1988-07-01       Impact factor: 47.728

Review 7.  FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy?

Authors:  Christian Fischer; Massimiliano Mazzone; Bart Jonckx; Peter Carmeliet
Journal:  Nat Rev Cancer       Date:  2008-12       Impact factor: 60.716

8.  Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts.

Authors:  Charles E Murry; Mark H Soonpaa; Hans Reinecke; Hidehiro Nakajima; Hisako O Nakajima; Michael Rubart; Kishore B S Pasumarthi; Jitka Ismail Virag; Stephen H Bartelmez; Veronica Poppa; Gillian Bradford; Joshua D Dowell; David A Williams; Loren J Field
Journal:  Nature       Date:  2004-03-21       Impact factor: 49.962

Review 9.  Platelets and stromal cell-derived factor-1 in progenitor cell recruitment.

Authors:  Konstantinos Stellos; Meinrad Gawaz
Journal:  Semin Thromb Hemost       Date:  2007-03       Impact factor: 4.180

10.  Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC.

Authors:  Ralf Hass; Cornelia Kasper; Stefanie Böhm; Roland Jacobs
Journal:  Cell Commun Signal       Date:  2011-05-14       Impact factor: 5.712

View more
  3 in total

Review 1.  Molecular regulation of arteriovenous endothelial cell specification.

Authors:  Jennifer Fang; Karen Hirschi
Journal:  F1000Res       Date:  2019-07-29

2.  Role of Canagliflozin on function of CD34+ve endothelial progenitor cells (EPC) in patients with type 2 diabetes.

Authors:  Seshagiri Rao Nandula; Nabanita Kundu; Hassan B Awal; Beda Brichacek; Mona Fakhri; Nikhila Aimalla; Adrian Elzarki; Richard L Amdur; Sabyasachi Sen
Journal:  Cardiovasc Diabetol       Date:  2021-02-13       Impact factor: 9.951

3.  Stem cell therapy targeting the right ventricle in pulmonary arterial hypertension: is it a potential avenue of therapy?

Authors:  Fanny Loisel; Bastien Provost; François Haddad; Julien Guihaire; Myriam Amsallem; Bojan Vrtovec; Elie Fadel; Georges Uzan; Olaf Mercier
Journal:  Pulm Circ       Date:  2018-02-26       Impact factor: 3.017

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.